Celldex second quarter net loss increases to $10.2 million

[News]

Celldex Therapeutics, Inc. today reported financial results for the second quarter ended June 30, 2011. Celldex reported a net loss of $10.2 million, or $0.27 per share, for the second quarter of 2011 compared to a net loss of $9.5 million, or $0.30 per share, for the second quarter of 2010.

More... (http://www.news-medical.net/news/20110803/Celldex-second-quarter-net-loss-increases-to-24102-million.aspx)